Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GRAMD4 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | PSD3 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | SIDT2 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | C19orf57 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | GLT1D1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CCDC188 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | DYDC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | HES6 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | IER3IP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | PLXNB3 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |